Antitumor agents--dose response curve clinical and experimental considerations
Frei, E.
Experimental Hematology 7(Suppl 5): 262-264
1979
ISSN/ISBN: 0301-472X PMID: 263243 Document Number: 151909
Document emailed within 1 workday
Related Documents
Wheeler, R.H.; Ensminger, W.D.; Thrall, J.H.; Anderson, J.L. 1982: High-dose doxorubicin: an exploration of the dose-response curve in human neoplasia Cancer Treatment Reports 66(3): 493-498Yoshimasu, T.; Oura, S.; Hirai, I.; Kokawa, Y.; Okamura, Y.; Furukawa, T. 2005: Dose response curve of paclitaxel measured by histoculture drug response assay Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(4): 497-500
Fitzgerald, M.G. 1971: The establishment of a normal human population dose-response curve for lymphocytes cultured with PHA (phytohaemagglutinin) Clinical and Experimental Immunology 8(3): 421-425
Appleton, B.S.; Goetchius, M.P.; Campbell, T.C. 1982: Linear dose-response curve for the hepatic macromolecular binding of aflatoxin B1 in rats at very low exposures Cancer Research 42(9): 3659-3662
Chen, X.; Feng, Y.; Luo, Y.; Yuan, Y.; He, T.; Zeng, J. 2001: The effect of leukotriene antagonist on the parameters of dose-response curve obtained after methacholine challenge test Hua Xi Yi Ke da Xue Xue Bao 32(4): 543-546
Reinglass, J.L. 1974: Dose response curve of intravenous glycerol in the treatment of cerebral edema due to trauma. A case report Neurology 24(8): 743-747
Morcillo, E.; Bedate, H.; Esplugues, J. 1980: Failure of beta-blockers to modify the inhibitory dose-response curve to sodium nitrite in isolated rat aorta Archivos de Farmacologia y Toxicologia 6(1): 11-16
Whitfield, J.B.; Fletcher, L.M.; Murphy, T.L.; Powell, L.W.; Halliday, J.; Heath, A.C.; Martin, N.G. 1998: Smoking, obesity, and hypertension alter the dose-response curve and test sensitivity of carbohydrate-deficient transferrin as a marker of alcohol intake Clinical Chemistry 44(12): 2480-2489
Pöch, G. 1981: Quantitative estimation of potentiating or inhibitory effects of similarly acting drugs in combination. Advantages of a dose-response curve method over the isoboles-method Arzneimittel-Forschung 31(7): 1135-1140
Czekanowski, R.; Kuźniar, B. 1985: Analysis of the correlation between the dose-response curve for prostaglandin F2alpha and the progress of pregnancy, cervix ripening, pharmacologic estrogen premedication and Partusisten administration in prostaglandin-induced labor Zentralblatt für Gynakologie 107(2): 79-83
Massa, S.; Stefancich, G.; Artico, M.; Corelli, F.; Silvestri, R. 1987: Potential antitumor agents. I. Synthesis of pyrroloindazole derivatives related to the pyrroloindole moieties of the antitumor antibiotic CC-1065 Il Farmaco; Edizione Scientifica 42(8): 567-574
Tanaka, J.; Holden, S.A.; Herman, T.S.; Teicher, B.A. 1992: Response of subpopulations of the FSall C fibrosarcoma to low dose x-rays and various potential enhancing agents Anticancer Research 12(3): 1029-1033
Farmer, J.H.; Uhler, R.J.; Haley, T.J. 1977: An unbalanced experimental design for dose response studies Journal of Environmental Pathology and Toxicology 1(2): 293-299
Sobell, J.M.; Kalb, R.E.; Weinberg, J.M. 2009: Management of moderate to severe plaque psoriasis (part I): clinical update on antitumor necrosis factor agents Journal of Drugs in Dermatology: Jdd 8(2): 147-154
1980: Experimental evaluation of antitumor drugs in the USA and USSR and clinical correlations National Cancer Institute Monograph 1980(55): 1-179
Emanuel, N.M.; Vermel, E.M.; Ostrovskaya, L.A.; Korman, N.P. 1974: Experimental and clinical studies of the antitumor activity of 1-methyl-1-nitrosourea (NSC-23909) Cancer ChemoTherapy Reports 58(2): 135-148
Eastland, G.W.; Yang, G.; Thompson, T. 1983: Studies of rhenium carboxylates as antitumor agents. Part II. Antitumor studies of bis (mu-propionato) diaquotetrabromodirhenium (III) in tumor-bearing mice Methods and Findings in Experimental and Clinical Pharmacology 5(7): 435-438
Lazarová, Z.; Edelsteinová, S.; Lojda, Z. 1991: The antiatherogenic dose response effect of verapamil in an experimental atherosclerosis model in the rabbit Cor et Vasa 33(6): 480-491
Murasaki, M. 1996: Clinical dose dependence of anti-anxiety agents Seishin Shinkeigaku Zasshi 98(9): 612-621
Mauer, A.M.; Lampkin, B.C.; McWilliams, N.B. 1973: Effects of chemotherapeutic agents on cell cycle and cellular proliferation: basic and clinical considerations Transplantation Proceedings 5(3): 1181-1184